HUP0001302A3 - 4-aminoalkoxy-1h-benzimidazole derivatives, use of them for producing pharmaceutical compositions as dopamine autoreceptor (d2) agonists and pharmaceutical compositions containing them - Google Patents
4-aminoalkoxy-1h-benzimidazole derivatives, use of them for producing pharmaceutical compositions as dopamine autoreceptor (d2) agonists and pharmaceutical compositions containing themInfo
- Publication number
- HUP0001302A3 HUP0001302A3 HU0001302A HUP0001302A HUP0001302A3 HU P0001302 A3 HUP0001302 A3 HU P0001302A3 HU 0001302 A HU0001302 A HU 0001302A HU P0001302 A HUP0001302 A HU P0001302A HU P0001302 A3 HUP0001302 A3 HU P0001302A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- aminoalkoxy
- agonists
- benzimidazole derivatives
- compositions containing
- Prior art date
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 102000007527 Autoreceptors Human genes 0.000 title 1
- 108010071131 Autoreceptors Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 229960003638 dopamine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80127697A | 1997-02-18 | 1997-02-18 | |
| PCT/US1998/000613 WO1998035945A1 (en) | 1997-02-18 | 1998-01-13 | 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0001302A2 HUP0001302A2 (en) | 2001-05-28 |
| HUP0001302A3 true HUP0001302A3 (en) | 2001-07-30 |
Family
ID=25180658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001302A HUP0001302A3 (en) | 1997-02-18 | 1998-01-13 | 4-aminoalkoxy-1h-benzimidazole derivatives, use of them for producing pharmaceutical compositions as dopamine autoreceptor (d2) agonists and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0973749A1 (en) |
| JP (1) | JP2001509814A (en) |
| KR (1) | KR20000071129A (en) |
| CN (1) | CN1252793A (en) |
| AR (1) | AR011136A1 (en) |
| AU (1) | AU746717B2 (en) |
| BR (1) | BR9807701A (en) |
| CA (1) | CA2278700A1 (en) |
| HU (1) | HUP0001302A3 (en) |
| IL (1) | IL131158A0 (en) |
| NZ (1) | NZ336969A (en) |
| TW (1) | TW513415B (en) |
| WO (1) | WO1998035945A1 (en) |
| ZA (1) | ZA981309B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6541502B1 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| CN101597262A (en) * | 2002-03-05 | 2009-12-09 | 特兰斯泰克制药公司 | The list and the bicyclic pyrrole derivatives that suppress part and advanced glycation end product acceptor interaction |
| TWI517850B (en) | 2009-09-30 | 2016-01-21 | Ｖｔｖ治療有限責任公司 | Substituted imidazole derivatives and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| PT707007E (en) * | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | AMINO DERIVATIVES (TIO) ETER AS ACTIVE AGENTS IN THE CNS |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| KR20000035880A (en) * | 1996-08-27 | 2000-06-26 | 이곤 이 버그 | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
-
1998
- 1998-01-13 JP JP53572798A patent/JP2001509814A/en active Pending
- 1998-01-13 CN CN98804249A patent/CN1252793A/en active Pending
- 1998-01-13 WO PCT/US1998/000613 patent/WO1998035945A1/en not_active Application Discontinuation
- 1998-01-13 KR KR1019997007418A patent/KR20000071129A/en not_active Application Discontinuation
- 1998-01-13 NZ NZ336969A patent/NZ336969A/en unknown
- 1998-01-13 EP EP98902513A patent/EP0973749A1/en not_active Withdrawn
- 1998-01-13 AU AU59153/98A patent/AU746717B2/en not_active Ceased
- 1998-01-13 IL IL13115898A patent/IL131158A0/en unknown
- 1998-01-13 BR BR9807701-5A patent/BR9807701A/en not_active IP Right Cessation
- 1998-01-13 HU HU0001302A patent/HUP0001302A3/en unknown
- 1998-01-13 CA CA002278700A patent/CA2278700A1/en not_active Abandoned
- 1998-02-03 TW TW087101275A patent/TW513415B/en active
- 1998-02-11 AR ARP980100617A patent/AR011136A1/en not_active Application Discontinuation
- 1998-02-17 ZA ZA9801309A patent/ZA981309B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000071129A (en) | 2000-11-25 |
| IL131158A0 (en) | 2001-01-28 |
| ZA981309B (en) | 1999-08-17 |
| CN1252793A (en) | 2000-05-10 |
| JP2001509814A (en) | 2001-07-24 |
| WO1998035945A1 (en) | 1998-08-20 |
| AU5915398A (en) | 1998-09-08 |
| CA2278700A1 (en) | 1998-08-20 |
| EP0973749A1 (en) | 2000-01-26 |
| BR9807701A (en) | 2000-05-02 |
| AR011136A1 (en) | 2000-08-02 |
| AU746717B2 (en) | 2002-05-02 |
| TW513415B (en) | 2002-12-11 |
| HUP0001302A2 (en) | 2001-05-28 |
| NZ336969A (en) | 2001-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101599A3 (en) | Heterocyclically substituted amides, process for producing them, use of them and pharmaceutical compositions containing them | |
| HUP0103333A3 (en) | Pyrroloindoles, pyridoindoles and azepinoindiles as 5-ht2c agonists, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
| HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0103567A3 (en) | 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same | |
| HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0001943A3 (en) | Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
| HUP0105313A3 (en) | Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use | |
| HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0303118A3 (en) | Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them | |
| HUP0102732A3 (en) | Substituted amids, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0102922A3 (en) | 2,3-substituted indole compounds as cox-2 inhibitors, process for producing them and pharmaceutical compositions containing them | |
| HUP0102622A2 (en) | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them | |
| HU9800781D0 (en) | Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| HUP0103893A3 (en) | Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing them and use thereof | |
| HK1039122A1 (en) | Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
| PL356911A1 (en) | Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same | |
| AU2841199A (en) | Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine | |
| HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0101482A3 (en) | Piperidinyl and n-amidinopiperidinyl derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
| HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
| HUP0101098A3 (en) | Streptogramin derivatives, process for preparation thereof and compositions containing same |